Who’s Involved in ‘Project Tiger’ and What Do They Want in Cambridge?
A life sciences company is planning a big move to Cambridge, according to the Boston Business Journal. Dubbed “Project Tiger,’’ the move could mean hundreds of high-level jobs housed in up to 200,000 square feet of office and lab space.
From the BBJ:
[fragment number=0][fragment number=1]
Sounds exciting, right? So who’s behind Project Tiger?
No one knows for sure. During an interview with NECN, BBJ Managing Editor Craig Douglas said he’s heard from several sources the group may involve German pharmaceuticals giant Bayer AG, but that is not confirmed.
Earlier this month, Bayer made waves in the market when it sold a division to Boston Scientific for $415 million. According to the Boston Globe, the division makes a product used to remove blood clots.
The BBJ lists several potential Cambridge locations for Project Tiger, and promises more details in a Friday story.
To comment, please create a screen name in your profile
To comment, please verify your email address
Conversation
This discussion has ended. Please join elsewhere on Boston.com